3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
16
Rectal Neoplasms
4
Pancreatic Neoplasms
4
Stomach Neoplasms
3
Colonic Neoplasms
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Diabetes Mellitus, Insulin-Dependent, 12
2
Carcinoma, Non-Small-Cell Lung
2
Resectable MMR-deficient Solid Tumors
1
Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Cancer Metastatic
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Microsatellite Stable Rectal Carcinoma
1
Melanoma
1
Hemangiosarcoma
1
Gliosarcoma
1
Glioma
1
Glioblastoma
1
Fibrolamellar hepatocellular carcinoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Colorectal Cancer Metastatic
1
Carcinoma, Renal Cell
1
Interventions
Cyclophosphamide
61
Rituximab
50
fludarabine
34
Prednisone
33
Doxorubicin
28
Biopsy
26
Vincristine
25
Specimen Handling
22
Magnetic Resonance Spectroscopy
20
Bendamustine Hydrochloride
19
pembrolizumab
16
Lenalidomide
16
obinutuzumab
14
fludarabine phosphate
14
Etoposide
14
venetoclax
13
Tacrolimus
11
Mycophenolic Acid
10
Melphalan
10
Dexamethasone
10
zanubrutinib
9
ibrutinib
9
acalabrutinib
9
Radiotherapy
9
Gemcitabine
9
Cytarabine
9
Busulfan
9
Whole-Body Irradiation
8
Mesna
8
Filgrastim
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
balstilimab
×
1 year
×
Clear all
No trials found.